Vertex Pharmaceuticals Inc (VRTX)

Working capital turnover

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Revenue (ttm) US$ in thousands 10,984,000 10,582,900 10,283,600 10,120,000 9,803,200 9,596,700 9,444,700 9,144,300 8,863,500 8,628,770 8,277,080 7,873,370 7,499,400 7,066,960 6,622,470 6,355,190 6,147,530 5,935,020 5,347,582 4,763,428
Total current assets US$ in thousands 9,596,400 9,804,100 8,941,600 13,288,700 14,144,200 14,695,800 13,872,900 12,965,700 13,234,800 12,271,000 11,503,500 10,361,300 9,560,600 8,852,540 8,457,510 8,539,310 8,133,400 7,458,460 6,694,320 5,446,400
Total current liabilities US$ in thousands 3,564,600 3,973,100 3,547,200 3,795,900 3,547,400 3,599,400 3,352,100 3,026,200 2,742,100 2,609,300 2,556,200 2,180,200 2,142,000 1,914,260 1,836,450 1,944,050 1,877,500 2,004,030 1,798,640 1,538,750
Working capital turnover 1.82 1.81 1.91 1.07 0.93 0.86 0.90 0.92 0.84 0.89 0.93 0.96 1.01 1.02 1.00 0.96 0.98 1.09 1.09 1.22

December 31, 2024 calculation

Working capital turnover = Revenue (ttm) ÷ (Total current assets – Total current liabilities)
= $10,984,000K ÷ ($9,596,400K – $3,564,600K)
= 1.82

Vertex Pharmaceuticals Inc's working capital turnover has exhibited fluctuations over the period analyzed. The ratio started at 1.22 on March 31, 2020, reflecting that the company generated $1.22 in revenue for every dollar of working capital invested. However, the ratio decreased to 0.84 by December 31, 2022 before gradually recovering. Notably, an increase in working capital turnover indicates an improvement in efficiency in utilizing working capital to generate revenue.

The ratio saw a significant improvement to 1.91 on June 30, 2024, suggesting that Vertex Pharmaceuticals Inc was able to generate $1.91 in revenue for each dollar of working capital invested, which could be due to better management of its working capital components such as current assets and current liabilities. Overall, analyzing the working capital turnover can provide insights into how effectively the company is utilizing its working capital to support its operations and generate revenue.


See also:

Vertex Pharmaceuticals Inc Working Capital Turnover (Quarterly Data)